Heart Rhythm
Volume 7, Issue 2 , Pages 149-154 , February 2010

Intracardiac and extracardiac markers of inflammation during atrial fibrillation

  • Gregory M. Marcus, MD, MAS

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Gregory M. Marcus, University of California, San Francisco, 500 Parnassus Avenue, MUE 434, San Francisco, California 94143-1354
    • ,
  • Lisa M. Smith, MPH

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Karen Ordovas, MD

      Affiliations

    • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
    • ,
  • Melvin M. Scheinman, MD, FHRS

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Albert M. Kim, MD, PhD

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Nitish Badhwar, MBBS

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Randall J. Lee, MD, PhD

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Zian H. Tseng, MD, MAS

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Byron K. Lee, MD, MAS

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California
    • ,
  • Jeffrey E. Olgin, MD, FHRS

      Affiliations

    • Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California

Received 25 August 2009 ,Accepted 5 October 2009.

References 

  1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:854–906
  2. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180–1184
  3. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886–2891
  4. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006–3010
  5. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J. 2008;155:303–309
  6. Kallergis EM, Manios EG, Kanoupakis EM, et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart. 2008;94:200–204
  7. Marcus GM, Smith LM, Glidden DV, et al. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm. 2008;5:215–221
  8. Dittrich HC, Pearce LA, Asinger RW, et al. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study (Stroke Prevention in Atrial Fibrillation Investigators). Am Heart J. 1999;137:494–499
  9. Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J. Current concepts in the pathogenesis of atrial fibrillation. Am Heart J. 2009;157:243–252
  10. Yao SY, Chu JM, Chen KP, et al. Inflammation in lone atrial fibrillation. Clin Cardiol. 2009;32:94–98
  11. Shah SJ, Marcus GM, Gerber IL, et al. High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail. 2006;12:61–65
  12. Liuba I, Ahlmroth H, Jonasson L, et al. Source of inflammatory markers in patients with atrial fibrillation. Europace. 2008;10:848–853
  13. Singh U, Devaraj S, Jialal I. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem. 2009;55:361–364
  14. Nagaoka T, Kuo L, Ren Y, Yoshida A, Hein TW. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci. 2008;49:2053–2060
  15. Liuzzo G, Santamaria M, Biasucci LM, et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol. 2007;49:185–194
  16. Singh U, Devaraj S, Dasu MR, Ciobanu D, Reusch J, Jialal I. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol. 2006;26:2469–2475
  17. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  18. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543–1553
  19. Birks EJ, Burton PB, Owen V, et al. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation. 2000;102:III352–III358
  20. Janssen SP, Gayan-Ramirez G, Van den Bergh A, et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation. 2005;111:996–1005
  21. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 2005;95:764–767
  22. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation (A study in awake chronically instrumented goats). Circulation. 1995;92:1954–1968
  23. Corradi D, Callegari S, Maestri R, Benussi S, Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2008;5:782–796
  24. Page PL, Plumb VJ, Okumura K, Waldo AL. A new animal model of atrial flutter. J Am Coll Cardiol. 1986;8:872–879
  25. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation (Is atrial fibrillation an inflammatory complication?). Circulation. 2003;108(Suppl 1):II195–II199

 This work was made possible by Grant KL2 RR024130 from the National Center for Research Resources (NCRR), a division of the National Institutes of Health (Bethesda, MD), to Dr. Marcus and by an American Heart Association Western States Affiliate Beginning Grant-in-Aid Award (Menlo Park, CA) to Dr. Marcus.

PII: S1547-5271(09)01148-5

doi: 10.1016/j.hrthm.2009.10.004

Heart Rhythm
Volume 7, Issue 2 , Pages 149-154 , February 2010

Article Tools

* Image Usage & Resolution